Table 1 Patient demographics and clinical characteristics (n = 63)
From: Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study
| Variable | Value |
|---|---|
| Median age, years (range) | 65.0 (35–84) |
| Sex, male/female | 41/22 |
| Median body height, cm (range) | 163.8 (144.9–180.9) |
| Median body weight, kg (range) | 59.4 (39.6–80.5) |
| Median body surface area, m2 (range) | 1.67 (1.27–1.92) |
| Median body mass index, kg/m2 (range) | 22.3 (16.7–29.3) |
| Chemotherapeutic regimen, (n) | |
| VNR alone | 12 |
| VNR + CDDP | 45 |
| VNR + HER | 5 |
| VNR + GEM | 1 |
| Department | |
| Respiratory medicine | 26 |
| Thoracic surgery | 26 |
| Breast surgery | 11 |
| Median VNR dose, mg/body (range) | 37 (29–47) |
| Median total cycles, n (range) | 4 (1–16) |
| Administration, main route/side port | 19/44 |
| Drug formulation, branded/generic | 52/11 |
| History of diabetes mellitus, yes/no | 10/53 |
| Dose of dexamethasone used for premedication 13.2/9.9/6.6 mg | 38/6/19 |
| Hot compress with hot towel, yes/no | 14/49 |